Prophylactic antilymphocyte globulin and HLA-DR matching reduce the incidence of rejection after cadaveric kidney transplantation

Transplant Proc. 1987 Oct;19(5):3612-3.
No abstract available

MeSH terms

  • Acute Kidney Injury / prevention & control
  • Antilymphocyte Serum / therapeutic use*
  • Cadaver
  • Graft Rejection
  • HLA-D Antigens / analysis*
  • HLA-DR Antigens / analysis*
  • Humans
  • Immunosuppression Therapy
  • Kidney / immunology
  • Kidney Transplantation*

Substances

  • Antilymphocyte Serum
  • HLA-D Antigens
  • HLA-DR Antigens